Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rajiv Parmar"'
Publikováno v:
International Symposium on Microelectronics. 2018:000680-000684
In recent years, advancements in High Performance Computing and Photonics are driving towards high density semiconductor packaging requirements that are creating a need for the adoption of novel material sets. Glass has many attractive properties tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52a66d2cea3b3528fe895124cc3321c0
https://doi.org/10.4071/2380-4505-2018.1.000680
https://doi.org/10.4071/2380-4505-2018.1.000680
Publikováno v:
Current cardiology reviews.
The article has been withdrawn at the request of the editor of the journal "Current Cardiology Reviews" Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afac296750e0ab4dc6fa1654267f54c9
https://pubmed.ncbi.nlm.nih.gov/31657680
https://pubmed.ncbi.nlm.nih.gov/31657680
Autor:
Spyros Chatzivasileiadis, Rajiv Parmar, David M. Lorenzetti, Marco Bonvini, Javier Matanza, Sila Kiliccote, Michael Wetter, Rongxin Yin, Thierry S. Nouidui, Emre Can Kara
Publikováno v:
Proceedings of the IEEE, vol 104, iss 4
Cosimulation platforms are necessary to study the interactions of complex systems integrated in future smart grids. The Virtual Grid Integration Laboratory (VirGIL) is a modular cosimulation platform designed to study interactions between demand-resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4bc1f01a8da8a91ad11064cad11d43
https://doi.org/10.1109/jproc.2016.2520738
https://doi.org/10.1109/jproc.2016.2520738
Autor:
Dushyantha Jayaweera, Tahir Haque, Fahim Pyarali, Catherine Boulanger, Alexis Powell, Claudia Martinez, Roumen Iordanov, Rajiv Parmar, Michael A. Kolber, Gerardo Zablah, Barry E. Hurwitz
Publikováno v:
Journal of the American College of Cardiology. 73:1917
Highly active antiretroviral therapy (ART) has improved survival of HIV patients, accompanied by an increase in prevalence of cardiovascular disease and its complications, including pulmonary hypertension (PH). While this could be attributed to a hei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c7a487682fd354312cda377ba8d3ae0
https://doi.org/10.1016/s0735-1097(19)32523-9
https://doi.org/10.1016/s0735-1097(19)32523-9
Autor:
Orlando Gomez-Marin, Rajiv Parmar, Valeria Porras, Alex Gonzalez, Neil Schneiderman, Ivonne Hernandez Schulman, Claudia Martinez, Dalhila Solorzano, Barry E. Hurwitz, Meela Parker, Michael A. Kolber, Alejandro Chedebeau, Roumen Iordanov, Bonni Lang
Publikováno v:
Journal of the American College of Cardiology. 73:1870
Although HIV-infected patients on antiretroviral therapy (ART) containing abacavir (ABC) have been reported to have increased cardiovascular disease (CVD) mortality, studies of vascular function have reported inconsistent results. In this study, meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfbfae26ecdf6389ff53d42ab4391db5
https://doi.org/10.1016/s0735-1097(19)32476-3
https://doi.org/10.1016/s0735-1097(19)32476-3
Autor:
Sandra Chaparro, Vanessa Blumer, Gabriel A. Hernandez, Rajiv Parmar, Jonatan Nunez Breton, Italo Novoa
Publikováno v:
Journal of the American College of Cardiology. 71:A808
The use of Impella percutaneous ventricular assist devices in patients undergoing high risk percutaneous coronary interventions, electrophysiological studies or for the treatment of cardiogenic shock is increasing. Stroke is a devastating complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b15098f434d72bf624aff3b2fb2e406
https://doi.org/10.1016/s0735-1097(18)31349-4
https://doi.org/10.1016/s0735-1097(18)31349-4
Publikováno v:
Journal of the American College of Cardiology. 69:2064
Introduction: Heparin-induced thrombocytopenia (HIT) is associated with significant thromboembolic risk and reported mortality of 20%. Currently, the only FDA approved therapy for HIT is argatroban. Bivalirudin has been suggested as an alternative an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3465eeff97ab26972d151d8978aabc39
https://doi.org/10.1016/s0735-1097(17)35453-0
https://doi.org/10.1016/s0735-1097(17)35453-0
Autor:
Chrisovalantis Lakhiani, Michel Saint-Cyr, Angela Cheng, Rajiv Parmar, Georgette Oni, Kristin Rojas
Publikováno v:
Plastic and Reconstructive Surgery. 132:134-135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b22e77f24885de83c389226a58516c73
https://doi.org/10.1097/01.prs.0000436018.99618.77
https://doi.org/10.1097/01.prs.0000436018.99618.77
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.